Abstract 5864: Taletrectinib, a next generation selective ROS1 inhibitor, demonstrates a differentiated profile in ROS1 fusion models
Year: 2026
Type: conference-abstract
Source: Cancer Research
Authors: Hitisha Patel, Laura Heller, Kevin Bowman, Zheyi Hu, Irma M. Grossi, Max Pan, Gary Hattersley
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7148635733
Cites:
Cited by:
Related to: